| Entry |
|
|---|
| Name |
Dalzanemdor (USAN/INN) |
|---|
| Formula |
C27H43F3O2
|
|---|
| Exact mass |
456.3215
|
|---|
| Mol weight |
456.6243
|
|---|
| Structure |
|
|---|
| Efficacy |
Dementia therapeutic agent, Neurodegenerative diseases agent, NMDA receptor modulator |
|---|
| Comment |
Treatment of cognitive impairment in neurodegenerative disorder
|
|---|
| Target |
|
|---|
| Pathway |
| hsa04080 | Neuroactive ligand-receptor interaction |
|
|---|
| Brite |
Target-based classification of drugs [BR:br08310]
Ion channels
Ligand-gated ion channels
Glutamate (ionotropic), NMDA
GRIN (NMDAR)
D12788 Dalzanemdor (USAN/INN)
|
|---|
| Other DBs |
|
|---|
| LinkDB |
|
|---|
| KCF data |
ATOM 32
1 C1x C 8.2600 -15.8200
2 C1z C 8.2600 -17.2200
3 C1x C 9.4724 -17.9200
4 C2y C 10.6849 -17.2200
5 C1z C 10.6849 -15.8200
6 C1x C 9.4724 -15.1200
7 C2x C 11.8973 -17.9200
8 C1x C 13.1097 -17.2200
9 C1y C 13.1097 -15.8200
10 C1y C 11.8973 -15.1200
11 C1y C 14.3222 -15.1200
12 C1z C 14.3222 -13.7200
13 C1x C 13.1097 -13.0200
14 C1x C 11.8973 -13.7200
15 C1x C 16.7470 -15.1200
16 C1x C 16.7470 -13.7200
17 C1y C 15.5346 -13.0200
18 O1a O 7.0476 -17.9200
19 C1a C 7.0476 -16.5200
20 C1c C 15.5346 -11.6200
21 C1b C 16.7511 -10.9177
22 C1a C 14.3262 -10.9223
23 C1b C 17.9486 -11.6092
24 C1d C 19.1349 -10.9243
25 C1d C 20.3267 -11.6126
26 C1a C 19.8349 -9.7119
27 O1a O 18.4349 -9.7119
28 X F 21.5391 -12.3126
29 X F 21.0267 -10.4002
30 X F 19.6267 -12.8250
31 C1a C 14.3222 -12.3200
32 C1a C 10.6849 -14.4200
BOND 35
1 1 2 1
2 2 3 1
3 3 4 1
4 4 5 1
5 5 6 1
6 1 6 1
7 4 7 2
8 7 8 1
9 8 9 1
10 9 10 1
11 5 10 1
12 9 11 1
13 11 12 1
14 12 13 1
15 13 14 1
16 10 14 1
17 11 15 1
18 15 16 1
19 16 17 1
20 12 17 1
21 2 18 1 #Up
22 2 19 1 #Down
23 17 20 1
24 20 21 1
25 20 22 1 #Down
26 21 23 1
27 23 24 1
28 24 25 1
29 24 26 1 #Up
30 24 27 1 #Down
31 25 28 1
32 25 29 1
33 25 30 1
34 12 31 1 #Up
35 5 32 1 #Up
|
|---|
